down arrow

Grey Wolf Animal Health Corp.

  • Market Cap: Micro Cap
  • Industry: Finance
  • ISIN: CA3978851044
CAD
1.26
0.01 (0.8%)

Dec 04

TSX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

0.801.49
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Mar 25

  • INTEREST(HY) At CAD 0.72 MM has Grown at 152.65%
  • PRE-TAX PROFIT(Q) At CAD 0.08 MM has Fallen at -55.29%
  • NET PROFIT(Q) At CAD 0.03 MM has Fallen at -78.39%
2

With ROE of 2.63%, it has a very expensive valuation with a 1.61 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Finance

stock-summary
Market cap

CAD 43 Million (Micro Cap)

stock-summary
P/E

48.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

2.63%

stock-summary
Price to Book

1.45

Revenue and Profits:
Net Sales:
10 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.82%
0%
-3.82%
6 Months
28.57%
0%
28.57%
1 Year
20.0%
0%
20.0%
2 Years
82.61%
0%
82.61%
3 Years
40.0%
0%
40.0%
4 Years
-37.0%
0%
-37.0%
5 Years
0%
0%
0.0%

Grey Wolf Animal Health Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Grey Wolf Animal Health Corp. Adjusts Valuation Amid Mixed Financial Indicators and Growth Prospects

Grey Wolf Animal Health Corp. Adjusts Valuation Amid Mixed Financial Indicators and Growth Prospects

Grey Wolf Animal Health Corp. has experienced a recent adjustment in its evaluation, influenced by shifts in financial metrics and market position. Key indicators highlight a premium valuation, despite a flat quarterly performance. The company's long-term growth trajectory remains strong, though recent declines in profits may affect perceptions of profitability.

Read More
Grey Wolf Animal Health Corp. Faces Valuation Challenges Amidst Flat Financial Performance

Grey Wolf Animal Health Corp. Faces Valuation Challenges Amidst Flat Financial Performance

Grey Wolf Animal Health Corp. has recently experienced a change in its evaluation, reflecting shifts in financial metrics and market position. The company, classified as a microcap, faces challenges in profitability despite notable interest growth, with key performance indicators indicating a complex financial landscape.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
217.58%
EBIT Growth (5y)
59.00%
EBIT to Interest (avg)
1.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
53.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.36%
ROE (avg)
1.43%
Valuation key factors
Factor
Value
P/E Ratio
48
Industry P/E
Price to Book Value
1.61
EV to EBIT
25.98
EV to EBITDA
14.19
EV to Capital Employed
1.37
EV to Sales
2.19
PEG Ratio
42.36
Dividend Yield
NA
ROCE (Latest)
5.26%
ROE (Latest)
2.63%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 31.94% vs 7.46% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 33.33% vs 200.00% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.50",
          "val2": "7.20",
          "chgp": "31.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.10",
          "val2": "1.30",
          "chgp": "61.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.10",
          "chgp": "400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.80",
          "val2": "0.60",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "155.30%",
          "val2": "139.40%",
          "chgp": "1.59%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 5.51% vs 12.39% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.67% vs -76.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.80",
          "val2": "25.40",
          "chgp": "5.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.40",
          "val2": "3.00",
          "chgp": "13.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.60",
          "chgp": "16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.70",
          "val2": "0.60",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "71.00%",
          "val2": "61.20%",
          "chgp": "0.98%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
9.50
7.20
31.94%
Operating Profit (PBDIT) excl Other Income
2.10
1.30
61.54%
Interest
0.50
0.10
400.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.80
0.60
33.33%
Operating Profit Margin (Excl OI)
155.30%
139.40%
1.59%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 31.94% vs 7.46% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 33.33% vs 200.00% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
26.80
25.40
5.51%
Operating Profit (PBDIT) excl Other Income
3.40
3.00
13.33%
Interest
0.70
0.60
16.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.70
0.60
16.67%
Operating Profit Margin (Excl OI)
71.00%
61.20%
0.98%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 5.51% vs 12.39% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 16.67% vs -76.00% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Grey Wolf Animal Health Corp. stock-summary
stock-summary
Grey Wolf Animal Health Corp.
Finance
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."